Drugmakers, biotech VCs show ‘reinvigorated’ interest in osteoporosis treatments Shift by the FDA and frustration with existing therapies have created new opportunities

https://www.statnews.com/2026/09/23/biotech-vc-investors-new-opportunity-osteoporosis-treatments/ By Allison DeAngelisSept. 23, 2026 Biotech Startups and Venture Capital Reporter